Cytokine Regulation of Photoreceptor Gene Expression
光感受器基因表达的细胞因子调节
基本信息
- 批准号:8413002
- 负责人:
- 金额:$ 35.16万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2014-01-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos-AMP-activated protein kinaseAffinityAgonistAnabolismBindingBiogenesisBlindnessCell DeathCell SurvivalCessation of lifeCiliary Neurotrophic FactorConceptionsDataDatabasesDiseaseEventEyeFundingGene ExpressionGene MutationGenesGeneticGoalsGrantInheritedKnock-outKnockout MiceKnowledgeLearningLifeLightMediatingMetforminMitochondriaMitochondrial ProteinsMusMutateMutationNuclearOncogenesPIM1 genePhosphorylationPhosphotransferasesPhotoreceptorsPlayRegulationRetinaRetinal DegenerationRetinal PhotoreceptorsRoleSTAT3 geneSignal TransductionSignaling ProteinStressSystemTestingTranscription CoactivatorUp-Regulationabstractingbasecancer cellcytokinedesignhuman diseaseimprovedinherited retinal degenerationkillingsleukemia inhibitory factorleukemia inhibitory factor receptorneuroprotectionnew therapeutic targetoncostatin Mpreconditioningpreventpromoterreceptorrepairedresearch studyretinal neurontranscription factor
项目摘要
6. Project Summary/Abstract
Inherited retinal degenerations are characterized by the loss of retinal neurons (most often photoreceptors).
More than 150 genes in the Retnet database have been shown to cause some form of retinal degeneration
when the gene is mutated, indicating a strong genetic component to these diseases. Often, blindness isn't
congenital but is delayed until the 5th, 6th, or 7th decade of life. The genetic mutation is present at conception
and yet photoreceptors survive and function for decades with the deleterious mutation. This phenomenon
suggests that the retina has an endogenous system of self protection. By learning how this system of
endogenous protection functions, we may be able to exploit it to further delay or even prevent blindness
altogether. This project was designed to further our knowledge of the endogenous mechanisms by which
retinal photoreceptors are protected from cell death. The four aims of this proposal will: Determine whether
PIM kinases are required for induced protection of photoreceptors (aim 1). Determine whether induced
protection of retinal photoreceptors is brought about through increased mitochondrial biogenesis or
mitochondrial repair (aim 2). Determine whether inhibition of mitochondrial biogenesis or repair through
genetic mutation of PGC-1 activity prevents preconditioning induced protection (aim 3). Test new cytokines
that we developed for enhanced neuroprotective activity (aim 4).
6.项目摘要/摘要
遗传性视网膜变性的特征是视网膜神经元(最常见的是光感受器)的丧失。
Retnet数据库中的150多个基因已被证明会导致某种形式的视网膜退化
当基因发生突变时,表明这些疾病有很强的遗传成分。通常,失明并不是
先天的,但被推迟到生命的第五、第六或第七个十年。基因突变是在受孕时出现的
然而,光感受器在这种有害的突变中存活了几十年并发挥了作用。这一现象
这表明视网膜有一种内源性的自我保护系统。通过学习这个系统是如何
内源性保护功能,我们也许能够利用它来进一步延缓甚至预防失明
总而言之。这个项目的设计是为了加深我们对内生机制的了解
视网膜光感受器受到保护,免于细胞死亡。这项提案的四个目标将决定:
PIM激酶是光感受器诱导保护所必需的(目标1)。确定是否已诱导
视网膜光感受器的保护是通过增加线粒体的生物发生或
线粒体修复(目标2)。确定是否通过抑制线粒体的生物发生或修复
PGC-1活性的基因突变可防止预适应诱导的保护(目标3)。检测新的细胞因子
我们为增强神经保护活性而开发的药物(目标4)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John D Ash其他文献
John D Ash的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John D Ash', 18)}}的其他基金
Dual Targeting Mitochondria and GPCR in Retinal Protection
双靶向线粒体和 GPCR 在视网膜保护中的作用
- 批准号:
10383538 - 财政年份:2022
- 资助金额:
$ 35.16万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10477262 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10296291 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Transcriptional control of stress-induced resistance to retinal degeneration
应激诱导的视网膜变性抵抗力的转录控制
- 批准号:
10842755 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10028851 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10455542 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10247603 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜中视网膜代谢的调节剂
- 批准号:
10834510 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Administrative Supplement to Regulators of retinal metabolism in healthy and degenerating retinas
健康和退化视网膜视网膜代谢调节剂的行政补充
- 批准号:
10361928 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
相似海外基金
Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
- 批准号:
2867610 - 财政年份:2023
- 资助金额:
$ 35.16万 - 项目类别:
Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
- 批准号:
BB/W009633/1 - 财政年份:2022
- 资助金额:
$ 35.16万 - 项目类别:
Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
- 批准号:
459043 - 财政年份:2021
- 资助金额:
$ 35.16万 - 项目类别:
Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2020
- 资助金额:
$ 35.16万 - 项目类别:
Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10561642 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
- 批准号:
532989-2019 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
- 批准号:
2243045 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
- 批准号:
10359032 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
- 批准号:
428988 - 财政年份:2019
- 资助金额:
$ 35.16万 - 项目类别:
Studentship Programs